Antonio Raviele, MD, FEHRA, FESC, FHRS
Antonio Raviele is one of the Presidents of Venice Arrhythmias. Between 2008 and 2011 he was Chief of the Cardiology Division and Chief of the Cardiovascular Department of the Ospedale dell’Angelo of Mestre – Venice, Italy. He is now retired and works as cardiologist and arrhythmologist in his private office in Mestre-Venice.
He was the first to implant of transvenous defibrillator in Italy. Antonio Raviele has always played key roles within many of the most important cardiology associations and societies – such as ECAS, ESC and HRS – while also providing fundamental contributions as member of several task forces on related topics. He authored more than 200 peer-review publications on many aspects of cardiac arrhythmias, and was the editor of several books on arrhythmology. Besides, he’s a reviewer and member of the Editorial Board of some among the most renowned field journals, such as the JACC, EHJ, HR, JCE, Europace, PACE, JICE, JAF, JCM, GIC, etc. Dr. Raviele is also the President of ALFA– Aliance to Fight Atrial fibrillation – and President of the Scientific Committee of FIGHT AF! the awareness campaign against atrial fibrillation that very successfully debuted in 2011 – (to a highly gratifying success).
Apart from Venice Arrhythmias, he’s also been promoting, organizing and coordinating numerous other scientific meetings in the field of arrhythmology – and has been participating in many more as Invited Speaker and Chairperson, both on a national and on an international level.
Dr. Raviele is married with Mrs. Carmen: they have two children, Michele and Francesca, who has recently given them two adorable grandchildren, Edoardo and Carlotta.
Antonio Raviele is fond of literature and reading in general, music, visual arts and sport: he’s a huge fan of AC Milan, but also supports FC Unione Venezia. But above all, cinema is his greatest passion: a fascination that eventually gave birth – in 2011 – to HAB – HeArtBeats Venice Short Film Festival, the highly successful international event which took place in October 2011, after having been showcased during last year’s edition of the Venice Cinema Festival. Besides Dr. Raviele, HAB’s Jury featured many outstanding representatives from the cardiology, cinema and culture worlds – including Dr. Andrea Natale, Prof. A. John Camm, Prof. Douglas P. Zipes, as well as renowned film directors such as the great Krzysztof Zanussi, Rafal Wieczynski and Gennaro Nunziante, and novelist Nicolai Lilin – and, most of all, was presided by the greatest cinema maestro of our times, Mr. Francis Ford Coppola.
Andrea Natale, MD, FACC, FHRS, FESC
Executive Medical Director, Texas Cardiac Arrhythmia Institute
St. David’s Medical Center
Patients from around the world seek treatment from Dr. Natale. A undisputed leader in the field of electrophysiology, Dr. Natale is a dedicated clinician, academician and researcher.
Prior to his appointment as Executive Medical Director of the Texas Cardiovascular Arrhythmia Institute at St. David’s Medical Center, Dr. Natale was Section Head for the Department of Cardiac Pacing and Electrophysiology and as Medical Director for the Cleveland Clinic’s Center for Atrial Fibrillation. A member of task forces and international societies, received a patent for a device used to treat Atrial Fibrillation.
Dr. Natale is a faculty member at prestigious universities and leading scientific and medical institutions. He has been an invited lecturer at more than 300 international conferences and the author, co-author or editor of more than 600 published articles and books on pacing and electrophysiology. In addition to serving on the editorial boards of numerous medical journals, he is the editor-in-chief of the Journal of Atrial Fibrillation. Besides Venice Arrhythmias, he is the creator of EPLIVE, the first fully interactive meeting of his genre, where EP experts from the world over are invited to share their experience while observing live cases being performed in the state-of-the-art laboratories of TCAI in Austin, Texas.
Dr. Natale’s greatest reward is restoring his patients to a life free of cardiac arrhythmia. He pioneered a circumferential ultrasound vein-ablation system to correct atrial fibrillation and performed the procedure on the world’s first five patients. He also developed some of the current catheter-based cures for atrial fibrillation, and was the first electrophysiologist in the USA to perform percutaneous epicardial radiofrequency ablation, which is a treatment for people who fail conventional ablation. He has authored milestone papers on pivotal projects, such as PABA and RAAFT.
An extraordinary researcher and mentor, Dr. Natale has been bestowed upon many awards as a testament to his generosity and dedication to his patients and young electrophysiologists in training, among which the recent FIRST HUMANITARIAN AWARD for his scientific commitment and leadership.
Sakis Themistoclakis, MD
Head, EP section & AF Center
Department of Cardiothoracic & Vascular Medicine
Ospedale dell’Angelo, Venice-Mestre, Italy
Dr. Sakis Themistoclakis was born in Marigliano (Naples), Italy, on June 24th, 1964.
Following his graduation in Medicine from the Medical School of the “Federico II” University in Naples in 1991, he completed a 5-year degree in Internal Medicine in the Department of Internal Medicine at the “Federico II” University in Naples. In 2004 he completed another 4-year residency in Cardiology at the University of Padua.
From November 1996 to April 1998, he served as Senior Cardiac Electrophysiologist of the Electrophysiology Laboratory at Clinica Montevergine of Mercogliano (Avellino).
From April 1998 to June 2011, he was Senior Electrophysiologist at the Cardiology Unit of the “Umberto I” Hospital (now “Ospedale dell’Angelo”) in Mestre-Venice and since June 2011 he is the Director of the Cardiac Electrophysiology Section. Since 2004, he is also the Director of the Atrial Fibrillation Center.
In the year 2000 he trained at the Cardiac Electrophysiology Section of the University of California – San Francisco (USA), headed by Dr. Michel Lesh and Dr. Melvin Scheinman.
In 2002 he also trained at the Cardiac Electrophysiology Section of the Cleveland Clinic, (Cleveland, Oh, USA) directed by Dr. Andrea Natale. Under his mentorship, Dr. Themistoclakis perfected the ICE-guided pulmonary vein antrum isolation. In the same year, a collaborative research program was finalized between the EP Section at the Cleveland Clinic and the EP Department of the “Umberto I” Hospital in Mestre headed by Dr. Themistoclakis, who was in charge of the research projects.
He has remained at the helm of the EP research activities conducted at Department of Cardiovascular Medicine of the new Ospedale Dell’Angelo in close cooperation with the Texas Cardiac Arrhythmias at St. David’s Medical Center, in Austin, Texas, USA, headed by Dr. Andrea Natale. In this framework, under the leadership of Dr. Themistoclakis, some pivotal studies have been conducted, such as the first-in-human study on atrial fibrillation with laser balloon under endoscopic guidance as well as the study on the discontinuation of oral anticoagulation after successful AF ablation even in patients at high thromboembolic risk.
From 1997 to 2000 he has been a member of RETAC (Reunion of European Countries for the Treatment of Arrhythmias in Cardiology) supported by the European Union’s Leonardo da Vinci program.
Within the Italian Society of Arrhythmology and Cardiac Pacing (AIAC), Dr. Themistoclakiswas appointed General Secretary and co-chair of the AIAC Working Group for Catheter Ablation from April 2008 to April 2010; he was then AIAC’s Vice-President, (April 2010- March 2012). Currently, he chairs the AIAC Working Group for Catheter Ablation.
He is a member of the following scientific societies: European Heart Rhythm Association (EHRA), European Society of Cardiology (ESC), Italian Federation of Cardiology (FIC), ANMCO and AIAC.
Dr. Themistoclakis is also member of the Editorial Board of the JAFIB (Journal of Atrial Fibrillation).
Since 2002, he has been invited to serve as Course Director of training courses on Intracardiac Echocardiography, initially organized by Acuson-Siemens and thereafter by Biosense-Webster – on Intracardiac Echocardiography and CartoSound. He has also been involved in the educational programs by St. Jude Medical and by Sanofi.
From November 2008 through December 2010 and from September through December 2012 he was consultant for the Hospital S. Maria degli Angeli-Pordenone in the development and launch of their atrial fibrillation ablation program. In 2008 he was again consultant for the Hospital of Rovigo for their program of ablation of atrial fibrillation guided by intracardiac echocardiography.
Since the year 2001 he has been a fundamental member of the Organizing and Program Committees of Venice Arrhythmias, and has also been the Organizing Vice-President of ALFA (ALliance to Fight Atrial fibrillation), the association which organized the 2011 National Awareness Campaign on atrial fibrillation Stop FA /Fight AF in Italy.
In the past few years, he has been member of several scientific and organizational committees of various national and international meetings, a member of the Advisory Board of the Mediterranean Cardiology Meeting, and in 2012 he was Program Chair for the national meeting of the Italian Society of Arrhythmology and Cardiac Pacing.
Dr. Themistoclakis has participated as Chairman and/or Speaker to several international meetings on cardiac arrhythmias and has authored or co-authored about 200 publications, among book chapters, international journals, and abstracts. He has been invited to serve as a reviewer for the Journal of American College of Cardiology, the Journal of Cardiovascular Electrophysiology, the Journal of Atrial Fibrillation, the Journal of Interventional Cardiac Electrophysiology and the Giornale Italiano di Aritmologia e Cardiostimolazione. In the last few years, he has been invited to serve as Abstract Grader for the Heart Rhythm Society, the European Society of Cardiology and the European Heart Rhythm Association.
Dr Themistoclakis has also been as principal investigator or co-investigator in several clinical trials: currently, he is the national coordinator and member of the Steering Committee of the EAST (Early treatment of Atrial fibrillation for Stroke prevention) trial. He is also member of the Physician Advisory Committee of OAT (safety of Oral Anticoagulation Therapy withdrawal after successful PV antrum isolation in patients with atrial fibrillation and associated high risk factors for embolic events).